News and Trends 14 Nov 2022
Nuance Pharma’s RSV vaccine cleared for trial in China
Nuance Pharma says China’s Center for Drug Evaluation (CDE) has approved its investigational new drug (IND) application supporting its pivotal phase III clinical trial of MVA-BN RSV vaccine against respiratory syncytial…